Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Kiniksa Pharmaceuticals International, plc KNSA

Healthcare  —  Drug Manufacturers Specialty & Generic
75.08 (0.26) (0.35%) as of 25 Sep
Market cap
$5.9B
P/E
70.2×
Cash Flow Champion (5y)
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending)
Download Excel — free account

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Cash and Short Term Investments 525.93 468.09 414.07 352.10

+8 more quarters
Receivables 23.49 23.22 15.59 51.74
Inventory 70.93 73.14 54.90 41.40
Total current assets 668.63 594.17 527.18 475.53
Property, Plant, Equpment (Net) 2.58 1.99 1.94 1.66
Goodwill and Intangible Assets (Total) 14.75 15.00 15.25 15.50
Long Term Assets (Tax, Deferred) 190.97 193.63 198.15 201.29
Long-term assets (Other) 10.83 11.16 11.31 8.29
Total non-current assets 227.48 231.11 236.46 236.80
Total Assets 896.11 825.28 763.63 712.33
Accounts Payable 12.40 24.40 2.03 6.15
Accrued Expenses 134.78 108.35 112.04 94.22
Other current liabilities 20.05 20.69 22.13 20.52
Total current liabilities 171.25 156.61 139.18 123.59
Non-current Revenue (Deferred) 31.81 31.81 31.81 31.81
Non-current Liabilities (Other) 34.02 25.32 18.52 14.53
Total non-current liabilities 70.71 62.98 56.84 53.36
Total liabilities 241.96 219.59 196.03 176.95
Additional Paid In Capital 1,069.62 1,045.88 1,029.75 1,011.85
Common Stock (Net) 0.02 0.02 0.02 0.02
Retained Earnings (414.11) (439.55) (462.14) (476.34)
Common Equity (Total) 654.15 605.69 567.61 535.38
Shareholders Equity (Total) 654.15 605.69 567.61 535.38
Shareholders Equity and Liabilities (Total) 896.11 825.28 763.63 712.33
Shares (Common) 77.98 76.69 76.29 75.43
Shareholders Equity (Tangible) 639.40 590.69 552.36 519.88
Net Debt (525.93) (468.09) (414.07) (352.10)

Fold the line items

In millions of $ except per-share values · columns are period end dates